Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Income Tax Expense & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Income Tax Expense

LCTX Income Tax Expense

Latest reported-$5.28Mperiod endingJun 30, 2026

LCTX Income Tax ($100.00K → -$5.28M)

Annual income tax expense

High-resolution chart · PNG

LCTX income tax expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Income Tax Expense — Annual fiscal periods (USD)
Period ending	Income Tax Expense (USD)
Dec 31, 2025	-5,114,000
Dec 31, 2024	0
Dec 31, 2023	-1,803,000
Dec 31, 2022	541,000
Dec 31, 2021	0
Dec 31, 2020	-1,239,000
Dec 31, 2019	-7,407,000
Dec 31, 2018	-346,000
Dec 31, 2017	0
Dec 31, 2016	0
Dec 31, 2015	-4,516,000
Dec 31, 2014	-7,375,611
Dec 31, 2013	-3,280,695
Dec 31, 2012	0
Dec 31, 2011	-2,383,752
Dec 31, 2010	3,418,959
Dec 31, 2009	-60,224
Dec 31, 2008	-15,036
Dec 31, 2007	388,157
Dec 31, 2006	-88,714
Dec 31, 2005	-46,276
Dec 31, 2004	1,084,212
Dec 31, 2003	-2,076,732
Dec 31, 2002	789,654
Dec 31, 2001	49,888
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	100,000
Jun 30, 1998	-200,000
Jun 30, 1996	100,000
Jun 30, 1995	-100,000
Jun 30, 1994	-100,000
Jun 30, 1993	-100,000
Jun 30, 1992	100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.